CSPG4 and neoplasm: Furthermore, our data also illustrate the complexity in interpreting results from genetically engineered mice, as the data from deletion of Ng2/Cspg4 at tumor initiation probably do not necessarily pertain to the more clinically relevant experiment of Ng2/Cspg4 inhibition in established tumors.